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Introduction
Balloon valvuloplasty has established as an alternative
to surgery for the therapy of aortic valve stenosis in
childhood [4, 13]. Nevertheless, acute complica-
tions after balloon dilation leading to early death
(< 30 days) have been described [12] and the devel-
opment of aortic insufficiency remains an unwanted
complication during long term follow up [1, 6].
Therefore, the balloon valvuloplasty is stated to be a
palliative approach with less morbidity and mortality
compared to aortic valve surgery [8], especially in
critical ill neonates [12]. But the morbidity in catheter
interventional therapy is not fully eliminated [16].
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j Abstract Background Isolated aortic valve stenosis in childhood is
treated by balloon valvuloplasty. The role of independent risk factors for
the outcome remains unclear. Material and methods We analysed the
early and medium term outcome of balloon valvuloplasty in isolated
aortic valve stenosis in 44 pediatric patients with isolated, severe aortic
valve stenosis at an age younger than 18 years, who received a primary
balloon valvuloplasty during the last 5 years in our institution. We
evaluated the type of aortic valve morphology, age, clinical status, and
myocardial function at the time of the intervention as independent risk
factor. Results A significant early relief of the pressure gradient across
the aortic valve (P < 0.001) after balloon valvuloplasty was found. This
was independent of the aortic valve morphology. Two neonates with a
highly stenotic tricuspid aortic valve and severely compromised haemo-
dynamics died within the first 30 days after the intervention. During
medium term follow up (mean 22.5 months) we observed a functional
deterioration for the stenosis as well as for the insufficiency of the aortic
valve. ‘‘Symptoms before intervention’’ is an independent risk factors
(P < 0.001) for valvuloplasty failure. Patients at an ‘‘age at intervention £
28 days’’ (P = 0.02) and patients with ‘‘reduced myocardial systolic
function’’ (P = 0.01) had a shorter time to reintervention. Conclusions
The type of aortic valve morphology only has a weak predictive value for
the outcome of balloon valvuloplasty during medium term follow up.
Critical ill neonates with an impaired myocardial function are at a higher
risk for valvuloplasty failure.
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have been assumed to be possible risk factors
determining the outcome of balloon valvuloplasty
[11, 17].
Therefore, the aim of this retrospective study was
to analyse the early outcome and medium term follow
up results of balloon valvuloplasty of aortic valve
stenosis in childhood with special regard to aortic
valve morphology and to point out other possible risk
factors for valvuloplasty failure.
Material and methods
j Patients
Between October 2001 and September 2006 all con-
secutive patients at an age younger than 18 years
treated for aortic valve stenosis with balloon val-
vuloplasty in our institution were analysed retro-
spectively. Medical records, angiographies,
echocardiographic and haemodynamic data were re-
viewed.
All patients had a native aortic valve stenosis and
no further congenital heart disease of haemodynamic
relevance. Patients with coexisting aortic valve
insufficiency more than grade 1 did not receive a
valvuloplasty [5].
The clinical status was defined as ‘‘normal’’ in
asymptomatic patients, and as ‘‘reduced’’ in patients
with symptoms of dyspnoea and other signs of con-
gestive heart failure, and ductal dependency in case of
neonates.
The myocardial systolic function was assessed by
echocardiography and defined as ‘‘normal’’ by a
shortening fraction >29%, and as ‘‘reduced’’ by a
shortening fraction £29%. The morphology of the
aortic valve was classified as functionally bicuspid,
anatomically bicuspid, or tricuspid by echocardiog-
raphy [18]. The valve morphology itself was no
exclusion criteria to perform balloon valvuloplasty for
aortic valve stenosis. The aortic valve gradient was
measured by continuous wave Doppler technique.
The peak pressure gradient was calculated from the
peak flow velocity, respectively, the mean gradient
from the time-velocity integral of the Doppler curve.
Further follow up was obtained by clinical evalu-
ation and two-dimensional and Doppler echocardi-
ography. Study end points were reintervention either
by a second catheter intervention or surgery, an aortic
valve insufficiency grade 4, death, and end of follow
up.
Valvuloplasty failure was defined as reintervention
during medium term follow up, aortic valve insuffi-
ciency grade 4, and death. The study end points were
tested for the variables ‘‘age at intervention
£28 days’’, ‘‘symptoms before intervention’’, ‘‘re-
duced myocardial systolic function (shortening frac-
tion £ 29%)’’, and ‘‘aortic valve morphology’’ as
possible risk factors.
Ethical approval for the study and data collection
were obtained according to the guidelines of the
ethical committee of the University of Zu¨rich.
j Technique
As an indication for balloon valvuloplasty a peak-to-
peak pressure gradient of more than 50 mm Hg in
patients with normal systolic myocardial function
(shortening fraction ‡ 30%, ejection fraction ‡ 50%)
was mandatory, while patients with an impaired sys-
tolic function (shortening fraction £ 29%, ejection
fraction £ 49%) were also included with a lower peak-
to-peak pressure gradient. All patients underwent the
procedure under general anaesthesia and fluoroscopic
guidance. Heparin was administered during the pro-
cedure with 100 IE/kg. The balloon valvuloplasty was
performed retrograde via a femoral access in all cases,
as described recently by Mullins [14]. Balloon size was
determined by the diameter of the aortic valve
annulus in systole measured by two-dimensional
echocardiography as well as by angiography in two
planes. The initial balloon diameter was 80%–90% of
the size of the aortic valve annulus. The procedure
was performed in ‘‘temporary cardiac arrest’’ by rapid
pacing of the right ventricle in one patient and by an
intravenous bolus injection of adenosine in one pa-
tient. After balloon valvuloplasty a satisfactory result
was defined as a reduction of the peak-to-peak pres-
sure gradient of at least 50% or a residual gradient of
less than 25 mm Hg. If this pressure gradient reduc-
tion could not be achieved, a redilation was per-
formed with a larger balloon. No further intervention
was performed in any case, if a severe aortic valve
insufficiency was detected in the following angiogra-
phy.
j Statistics
Group data are presented in percentages or relative
frequencies for discrete data and as median and range
for continuous variables or as means and standard
deviations, if the data are approximately normally
distributed. Comparisons of continuous and ordinal
variables between independent groups were per-
formed with the Mann–Whitney U test or t test, if
variables were approximately normally distributed.
Comparison of continuous and ordinal variables for
the same group in two different settings (paired data)
was performed with the Wilcoxon signed rank test or
588 Clinical Research in Cardiology, Volume 97, Number 9 (2008)
 Steinkopff Verlag 2008
paired t test. Differences in proportions between
independent groups were tested by the chi square test
or Fisher exact test, as appropriate.
Survival analysis was performed with the Kaplan
Meier method and the Log-rank test for differences in
time-to-event between independent groups. The
combined effect of several risk factors on time-to-
event was analysed with a Cox regression.
A P value equal or less than 0.05 was considered
statistically significant.
Statistical analysis was conducted with SPSS 11 for
Mac OS X.
Results
j Patients and clinical status
Fourty-five patients were treated for isolated severe
aortic valve stenosis with balloon valvuloplasty.
Complete follow up was available for 44 patients. A
functionally bicuspid aortic valve was found in 18
patients, an anatomically bicuspid aortic valve in 12,
and a tricuspid aortic valve in 14. The mean age at
intervention for all patients was 6.3 ± 5.9 years
(range 0–15.9 years). Eleven patients (25%) were
neonates at an age of £28 days at the time of inter-
vention, seven of them had a tricuspid valve mor-
phology (Table 1). The majority of the neonates
(63.6%) with aortic valve stenosis were symptomatic;
ductal dependency with retrograde flow of the aortic
arch was present in three patients (27.2%). In con-
trast, beyond the neonatal period the majority of the
patients were asymptomatic (P < 0.05). Seven pa-
tients (21.2%) beyond the neonatal period showed
mild symptoms of congestive heart failure such as
dyspnea. The myocardial function was reduced in
three neonatal patients (27.3%). Clinical pre- and
post-interventional conditions are summarized in
Table 1.
j Early outcome
The acute haemodynamic results of balloon valvulo-
plasty are summarized in Table 1. In all patients there
was a significant relief of the peak-to-peak pressure
gradient after balloon valvuloplasty of aortic valve
stenosis (functionally bicuspid, P < 0.001; anatomi-
cally bicuspid, P < 0.001; tricuspid, P < 0.001; all pa-
tients, P < 0.001). This relief of aortic valve stenosis
could also be found with the continuous wave (cw)
Doppler measurements before and the day after inter-
vention (pre-continuous wave Doppler gradient vs.
post-continuous wave Doppler gradient in functionally
bicuspid, P < 0.001; anatomically bicuspid, P < 0.001;
tricuspid, P = 0.002; all patients, P < 0.001).
In five patients (11.4%) acute complications within
30 days after the intervention occurred: An acute se-
vere aortic insufficiency in a 10-year-old boy with
previous normal myocardial function could be suc-
cessfully treated by an emergency aortic valve
reconstruction. The aortic valve was functionally
bicuspid, and the used balloon:annulus ratio was 1.0.
Two neonatal patients died 3 days and 20 days after
the intervention due to persistent congestive heart
Table 1 Results of aortic balloon valvuloplasty in 44 children
All patients Neonates (age £ 28 days) Older children (age > 28 days)
Patients 44 11 33
Age [years] 6.3 ± 5.9 (0–15.9) 0.02 ± 0.02* (0–0.1) 8.3 ± 5.4* (0.1–15.9)
Body weight [kg] 24.9 ± 21.2 (2.2–67.0) 3.4 ± 0.7* (2.2–4.6) 32.0 ± 19.8* (3.1–67.0)
Symptomatic patients, n = [%] 14 [31.8%] 7 [63.6%]* 7 [21.2%]*
Reduced LV function, n = [%] 8 [18.2%] 3 [27.3%] 5 [15.2%]
Aortic insufficiency grade 1, pre dilation 13 [29.6%] 0* 13 [39.4%]*
Balloon:annulus ratio 0.94 ± 0.07 (0.82–1.17) 0.94 ± 0.09 (0.82–1.07) 0.94 ± 0.07 (0.84–1.17)
Peak-to-peak gradient, pre dilation [mm Hg] 55 ± 19** (21–110) 62 ± 24** (21–110) 52 ± 16** (29–90)
Peak-to-peak gradient, post dilation [mm Hg] 19 ± 11** (0–55) 17 ± 10** (5–40) 19 ± 11** (0–55)
Doppler gradient post dilation [mm Hg] 37 ± 17 (8–97) 27 ± 15 (8–62) 40 ± 17 (18–97)
Acute complication (<30 days) 5 [11.4%] 3 [27.3%] 2 [6.1%]
Early death (£30 days) 2 [4.5%] 2 [18.2%] 0
Late death (>30 days) 0 0 0
Follow up [months] 22.5 ± 14.2 (0.1–48) 15.9 ± 17 (0.1–48) 24.8 ± 12.6 (0.1–48)
Doppler gradient, at last follow up [mm Hg] 41 ± 21 (10–104) 39 ± 22 (18–90) 42 ± 21 (10–104)
Aortic insufficiency < grade 4, at last follow up 16 [36.4%] 5 [45.5%] 11 [33.0%]
Aortic insufficiency grade 4, at last follow up 3 [6.8%] 2 [18.1%] 1 [3.0%]
Reintervention, n = [%] 11 [25%] 4 [36.4%] 7 [21.2%]
Valvuloplasty failure, n = [%] 13 [29.6%] 6 [54.5%]* 7 [21.2%]*
Data are displayed as mean ± SD (range)
* P < 0.05 (Mann–Whitney U test for group comparison)
** P < 0.05 (t test for pre vs. post dilatation comparison)
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failure. Both neonates were ductal dependent before,
presented signs of endocardial fibroelastosis with
systolic as well as diastolic myocardial dysfunction
and had a tricuspid valve morphology. Thrombosis of
the femoral artery developed in one patient. In one
patient surgical reconstruction of the femoral artery
was necessary due to technical problems with failure
of complete removal of the balloon through the
femoral sheath.
j Medium term follow up
The mean follow up was 22.5 months for all patients.
The medium term follow up results of balloon val-
vuloplasty for aortic valve stenosis are described in
Table 1. The mean cw Doppler gradient at last follow
up was higher compared to the early value post
dilation, but did not reach statistical significance
neither for all patients together nor for the different
types of aortic valve morphology (functional bicuspid,
P = 0.31; anatomic bicuspid, P = 0.89; tricuspid,
P = 0.10; all patients, P = 0.07). Patients with tricus-
pid aortic valves developed during medium term
follow up an increase of the grade of aortic insuffi-
ciency, and suffered from a higher reintervention rate,
and higher valvuloplasty failure rate compared to
patients with functionally or anatomically bicuspid
aortic valve, but this trend for the tricuspid aortic
valve morphology could not be shown for patients
beyond the neonatal period (Fig. 1).
Patients with reduced myocardial systolic function
(Kaplan Meier survival analysis, P = 0.01), with
symptoms before intervention (Kaplan Meier survival
analysis, P = 0.01) as well as patients at an age at
intervention £28 days (Kaplan Meier survival analy-
sis, P = 0.02) had a significantly shorter time to re-
intervention compared to patients with a normal
systolic function, respectively, no symptoms before
interventions as well as patients at older age at
intervention (>28 days) (Fig. 2).
j Valvuloplasty failure
Valvuloplasty failure was defined as reintervention
during follow up, aortic valve insufficiency grade 4, and
death. A Cox regression analysis with valvuloplasty
failure as primary endpoint was performed for the
following explanatory variables ‘‘age at intervention
£28 days’’, ‘‘symptoms before intervention’’, ‘‘reduced
myocardial systolic function (shortening fraction £
29%)’’, and ‘‘aortic valve morphology’’. It revealed
‘‘symptoms before intervention’’ as a significant risk
factor for valvuloplasty failure (both in a multivariable
logistic regression with all variables, P < 0.001, and in a
univariable logistic regression, P < 0.001). The type of
aortic valve morphology was not a significant risk
factor for valvuloplasty failure (P = 0.08).
Discussion
In our study, we analysed the early and medium term
outcome after balloon valvuloplasty of aortic valve
stenosis in childhood. We focussed on different risk
factors influencing the results. The impact of the type
of aortic valve morphology was weak in our study,
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Fig. 1 Kaplan Meier survival analysis comparing the time to reintervention for
the three different types of aortic valve morphologies in paediatric patients
after balloon valvuloplasty of the aortic valve. A significant difference between
the patients with tricuspid aortic valve morphology, which had the poorest
outcome, compared to anatomically bicuspid aortic valve morphology
(P = 0.047) and the functional bicuspid aortic valve morphology (P = 0.36)
regarding all patients (up). In patients older 28 days (down) there was no
significant difference between the three types of aortic valve morphology
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because during early outcome we found a significant
relief of the pressure gradient, which was independent
of the type of aortic valve morphology (Table 1).
Second, during medium term follow up we observed a
moderate increase of the residual Doppler gradient,
and parallel to this a moderate increase of aortic valve
insufficiency, which was also independent of the type
of aortic valve morphology. There was a moderate
trend towards worse results in medium term follow
up for patients with tricuspid aortic valve morphol-
ogy. In Kaplan Maier survival analysis the time to
reintervention of the patients with tricuspid aortic
valve was significantly shorter (P < 0.05) compared
with the time to reintervention in patients with ana-
tomically bicuspid aortic valve morphology (Fig. 1,
up). But by ruling out the neonates in the Kaplan
Meier survival analysis, in the patients at age older
28 days the type of aortic valve morphology was no
significant discriminating factor (Fig. 1, down).
Despite aortic valve morphology, we could focus
on other independent risk factors for valvoulplasty
failure in medium term follow up. In uni- and multi-
variable logistic regression analysis ‘‘symptoms before
intervention’’ is a significant risk factor for valvulo-
plasty failure. This observation was confirmed by the
circumstance that the time of reintervention was
significantly shorter in those patients, who had a
‘‘reduced myocardial systolic function (shortening
fractions £ 29%)’’ (Fig. 2) before intervention, and
who were treated early at an ‘‘age at interven-
tion £ 28 days’’. These factors of ‘‘young age at
intervention’’, ‘‘clinical symptoms’’, and ‘‘myocardial
systolic insufficiency’’ incorporates and confirms
separate observations of previous investigators [1–3,
6, 7, 9–11, 13, 14] (Table 2). Reich et al. clearly
showed that functionally bicuspid aortic valve mor-
phology is an independent risk factor for aortic valve
insufficiency after balloon dilation [16]. In our study,
the results of aortic valvuloplasty in patients with
functionally bicuspid aortic valve lie in between the
more positive results of patients with anatomically
bicuspid aortic valve and the more negative results of
patients with tricuspid aortic valve morphology
(Fig. 1, left). The poor outcome in patients with tri-
cuspid aortic valve morphology in medium term fol-
low up may be partly explained by the high number
(50%) of neonates in the group of patients with
tricuspid aortic valve morphology in our study
(Table 1). Consecutively a higher number of patients
in this group with symptoms before intervention
(50%) and reduced myocardial function before
intervention lead to a higher rate of acute complica-
tions, severe aortic insufficiency, need for reinter-
vention or even death (Table 1). Compared to
patients with tricuspid aortic valve morphology the
patients with anatomically bicuspid aortic valve
morphology had the significant longer (P < 0.05) time
to reintervention during medium term follow up. The
reintervention rate of patients with anatomically
bicuspid aortic valve was only 8.3%, and no patient
developed aortic insufficiency grade 4 during the
follow up period of 2 years (Table 1).
In conclusion, this study shows that aortic valve
morphology is not a risk factor for the early outcome
in balloon valvuloplasty of aortic valve stenosis in
children, but is only a weak risk factor during med-
ium term follow up. Other independent risk factors as
‘‘symptoms before intervention’’, ‘‘age at interven-
tion £ 28 days’’, and ‘‘reduced myocardial systolic
function (shortening fraction £ 29%)’’ have to be ta-
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Fig. 2 Kaplan Meier survival analysis comparing the time to reintervention in
paediatric patients after balloon valvuloplasty of the aortic valve. There was a
significant difference of the time to reintervention between patients with
normal or reduced myocardial systolic function (P = 0.01) (up), and between
patients with or without clinical symptoms at the time of interventions
(P = 0.02) (down)
W. Knirsch et al. 591
Balloon valvuloplasty in aortic valve stenosis in childhood
ken into account for the risk stratification of balloon
valvuloplasty of aortic valve stenosis during medium
term follow up.
Our experience on the basis of these data raise the
question of interventional vs. surgical relief of aortic
valve stenosis, especially for the high risk neonatal
group with reduced myocardial function. But the
comparison between interventional and surgical
treatment was not the primary aim of our study.
Nevertheless, in our institution, we pursue the deci-
sion-making process in a multidisciplinary approach
together with the complete team of cardiac surgery,
interventional cardiology, pediatric intensive care,
and anaesthesiology in a highly individualized rela-
tion to every single patient.
Table 2 Overview of clinical studies evaluating follow up of balloon valvuloplasty in aortic valve stenosis in children
Author Patients Age Follow up
Follow up
[years]
Rate of significant
restenosis (%)
Rate of significant
regurgitation
Rate of
reintervention (%)
Reich et al. [16] 189 5 weeks–23 years 7.5 17 22% 29
Moore et al. [13] 148 1 month–20 years 3.9 17 7% 25
Pedra et al. [15] 87 6 months–17.9 years 6.3 20 17% 37
Jindal et al. [7] 74 1–20 years 5.5 20 21% 14
Demkow et al. [2] 45 3.5–23 years 6.2 22 Early 18%; late 29% 33
Latiff et al. [10] 42 1 day–6 months 5.4 12 26% 38
Egito et al. [3] 33 1 day–28 days 4.3 35 14% 40
Galal et al. [6] 26 6 weeks–20 years 6.0 23 27% 23
Kuhn et al. [9] 22 3 month–19.9 years 5.1 32 14% 46
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